Incyte Corp (NASDAQ: INCY) has reported earnings for its first fiscal quarter (ending March 31) of $0.76 versus $0.10 for the same period a year ago — an increase of 660%. Relative to the consensus estimate of $1.29, this was a shortfall of $-0.53. For the latest four quarters through March 31, E.P.S. were $3.33 compared to $1.47 a year ago — an increase of 127%.
Recent Price Action
Incyte Corp (NASDAQ: INCY) stock declined slightly by -1.0% on 4/30/24. The stock closed at $52.05. Moreover, exceptionally high trading volume at 258% of normal accompanied the decline. The stock has been weak relative to the market over the last nine months but is unchanged during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, INCY is expected to continue to be an important Value Builder.
Incyte has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Incyte has a good Appreciation Score of 77 but a slightly negative Power Rating of 31, leading to the Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment